Drug Profile
HLO 7
Latest Information Update: 24 Aug 2001
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Antidotes
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Poisoning
Most Recent Events
- 24 Aug 2001 No-Development-Reported for Poisoning in Canada (Injection)
- 24 Aug 2001 No-Development-Reported for Poisoning in Germany (Injection)
- 24 Aug 2001 No-Development-Reported for Poisoning in Netherlands (Injection)